ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Breast Cancer
Ovarian Cancer
Endometrial Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma

Prostate Cancer trials near Valencia, VC, ESP:

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisi...

Enrolling
Prostatic Disease
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Drug: Gedatolisib
Drug: Darolutamide

Phase 1, Phase 2

Celcuity

Valencia, Spain and 12 other locations

primary trial objective is to demonstrate that ODM-201 produces prostate-specific antigen (PSA) response rates at 24 weeks (defined as ≥80% ...

Active, not recruiting
Prostate Cancer
Drug: ADT
Drug: ODM-201

Phase 2

European Organisation for Research and Treatment of Cancer (EORTC)

Valencia, Spain and 12 other locations

The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...

Enrolling
Metastatic Prostate Cancer
Drug: AZD9574
Drug: AZD0516

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Valencia, Spain and 50 other locations

Metastatic prostate cancer is an incurable disease that typically spreads beyond the prostate. The standard of care is to ...

Active, not recruiting
Metastatic Hormone-sensitive Prostate Cancer
Drug: ADT (androgen deprivation therapy)
Drug: Nivolumab 10 MG/ML

Phase 2, Phase 3

Spanish Oncology Genito-Urinary Group

Valencia, Spain and 29 other locations

Effects of Saruparib (AZD5305) Alone, Darolutamide Alone, and in Combination Given Prior to Radical Prostatectomy in Men with Newly Diagnosed Prostate...

Enrolling
Prostate Cancer
Drug: Saruparib (AZD5305)
Drug: Darolutamide

Phase 1

AstraZeneca
AstraZeneca

Valencia, Spain and 18 other locations

with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials....

Enrolling
Prostate Cancer
Drug: AAA617

Phase 4

Novartis
Novartis

Valencia, Spain and 53 other locations

docetaxel with or without local radiotherapy with or without abiraterone acetate and prednisone in patient with metastatic hormone-naïve prostate...

Active, not recruiting
Metastatic Prostate Cancer
Other: Androgen Deprivation Therapy
Drug: abiraterone acetate

Phase 3

Unicancer
Unicancer

Valencia, Spain and 76 other locations

with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....

Enrolling
Prostate Cancer
Drug: Saruparib
Drug: Abiraterone + Prednisolone/Prednisone

Phase 3

AstraZeneca
AstraZeneca

Valencia, Spain and 296 other locations

This is a phase III, randomized, open-label, multi-center study to assess the efficacy of treatment intensification with docetaxel plus apalutamide a...

Begins enrollment in 2 months
Metastatic Hormone-sensitive Prostate Cancer
Drug: Apalutamide (Erleada™) 60 mg or 240 mg tablets
Drug: Docetaxel

Phase 3

Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD

Valencia, Valencia, Spain and 55 other locations

of ADT +/- darolutamide in castration-naïve de novo metastatic prostate cancer patients with vulnerable functional ability who have...

Enrolling
Prostate Cancer Metastatic
Drug: Androgen deprivation therapy
Drug: Darolutamide 300 mg

Phase 3

Unicancer
Unicancer

Valencia, Spain and 89 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems